Life Science Companies are Litigation Targets for Unhappy Investors Post author:Sam Post published:February 22, 2018 Post category:BioPharma Life science companies are popular targets for securities fraud litigation. Source: BioSpace You Might Also Like PURE Bioscience Receives FDA Interim Safety Determination Authorization To Test Higher Concentrations Of SDC-Based PURE Control Antimicrobial As A Poultry Processing Aid February 5, 2017 AEterna Zentaris To Announce Second Quarter 2017 Financial And Operating Results On August 10, 2017 August 6, 2017 Bleeding Money, s NantHealth Restructures and Lays Off 300 August 10, 2017
PURE Bioscience Receives FDA Interim Safety Determination Authorization To Test Higher Concentrations Of SDC-Based PURE Control Antimicrobial As A Poultry Processing Aid February 5, 2017
AEterna Zentaris To Announce Second Quarter 2017 Financial And Operating Results On August 10, 2017 August 6, 2017
